4th In-House Impact: Life Sciences 2023 Wyndham Boston Beacon Hill, Boston

In-House Impact: Life Sciences is the only forum dedicated to legal leaders working within the life sciences industry. It represents a unique opportunity to gather with peers in pharma, biotech and medical device in-house legal teams to collaborate and carve out a new narrative for the legal function.

With the expectations of in-house legal teams ever changing alongside increased scrutiny from government agencies, join the only case- study led meeting that will enable you to learn the leadership development skills necessary to excel in your role as an in-house legal leader.

Speakers: Ahmed Mousa, Chief Business Officer, Senior Vice President and General Counsel, Pieris Pharmaceuticals, Beth Krewson, Senior Vice President and General Counsel, BlueRock Therapeutics, Chris Moore, General Counsel, Umoja, Chris Slavinsky, Chief Business and Legal Officer, Coherus Biosciences, Christopher Verni, General Counsel, Vigil Neuroscience, Derek Meisner, Chief Legal Officer and Corporate Secretary Legal, X4 Pharmaceuticals, Greg Chesmore, Chief Executive Officer, Gridiron Public Affairs/Strategic Government Affairs and Policy Leader, Gridiron Public Affairs, Guled Adam, General Counsel, Sobi NA, Irina Ridley, Chief Legal Officer, Neuropace, John Maher, Deputy General Counsel, Vice President, Privacy Officer, J. Knipper and Company, John Schiffhauer, SVP, Legal and Intellectual Property, Zymergen, Karen Gally, Vice President and General Counsel, Otsuka, Lara Dueppen P.h.D., Partner, Perkins Coie LLP, Lora Spencer, Principal Litigation and Investigations Counsel, Medtronic, Marty Lorenz, Chief Legal Officer and Corporate Secretary, Renal Care Solutions, Medtronic, Megan Filoon, General Counsel, Molecular Templates, Michael Wise, Partner, Perkins Coie LLP, Priscilla Fussell, General Counsel, Immunomic Therapeutics, Rupa Cornell, Vice President and Head Counsel for Vaccines Business Unit, Takeda Pharmaceutical, Shannon Moesaa, Vice President, Commercial and Healthcare Compliance Counsel, Karuna Therapeutics, Susan Lipsitz, Vice President, Associate General Counsel and Chief Compliance Officer, IQVIA, Ty Ward, General Counsel, Roche, Yingli Wang P.h.D., Partner, Perkins Coie LLP